Video

Q&A With Scott Solomon From Brigham & Women's Hospital: New Study Shows Improvement In Rehospitalization In Heart Failure Patients

Author(s):

Rehospitalization is becoming a growing concern in the health care field with health systems facing financial consequences if they do not reach certain benchmarks. A recent study of an approved medication showed benefits in this area that could help patients and providers alike.

Rehospitalization is becoming a growing concern in the health care field with health systems facing financial consequences if they do not reach certain benchmarks. A recent study of an approved medication showed benefits in this area that could help patients and providers alike.

Scott D. Solomon, MD, from Brigham & Women's Hospital discussed the new results of the Paradigm study looking at hospitalization and the impact of Valsartan/sacubitril and what it can mean for future care of patients with this condition during the American Heart Association's annual meeting in Orlando.

Related Videos
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.